Catalog No.: PC-38373Not For Human Use, Lab Use Only.
Senaparib (IMP4297) is a novel highly potent and selective oral PARP1/2 inhibitor with IC50 of 6.27 nM/1.57 nM, respectively, exhibits strong antitumor activity.
Senaparib (IMP4297) is a novel highly potent and selective, oral PARP1/2 inhibitor with IC50 of 6.27 nM/1.57 nM, respectively, exhibits strong antitumor activity.
Senaparib (IMP4297) has demonstrated 20-fold more potent than olaparib in vivo and showing strong antitumor activity in preclinical studies, IMP4297 is well-tolerated with significant anti-tumor activity in clinical investigations.
